Asparaginase is a hydrolase enzyme that catalyzes the hydrolysis of the amino acid L-asparagine into L-aspartic acid and ammonia. It is commonly derived from bacterial sources such as Escherichia coli and Erwinia chrysanthemi.
Asparaginase
| CAS No: | 9015-68-3 |
| EINECS No: | 232-776-1 |
| EC No: | 3.5.1.1 |
| Synonyms: | L-asparagine amidohydrolase, Colaspase, Elspar, Erwinase, Leunase, Kidrolase |
Product Summary
Biochemical Function & Mechanism of Action
Asparaginase functions by depleting extracellular L-asparagine, a vital amino acid that certain cells—particularly cancer cells—cannot synthesize due to low levels of asparagine synthetase. By eliminating L-asparagine, asparaginase starves these cells, leading to inhibited protein synthesis and cell death.
- Reaction: L-asparagine + H₂O → L-aspartic acid + NH₃
- Optimal pH: 8.0 (active in pH 7.0–8.6 range)
- Optimal temperature: 37°C (tends to lose activity above 45°C)
- Inhibitors: L-Aspartic acid, L-Glutamic acid, Cu²⁺, Hg²⁺, Zn²⁺
Applications in Scientific Research
- Used to investigate amino acid dependency and metabolic vulnerabilities in tumor cells.
- Assists in studies of nitrogen metabolism and enzyme-substrate specificity.
- Induces apoptosis in leukemic cells by depriving them of asparagine.
- Used as part of multi-drug regimens (e.g., with vincristine, prednisone, and methotrexate).
Packaging & Storage
- Available as white lyophilized powder.
- Store at 2-8°C (dry form); keep frozen at –20°C for long-term enzyme stability.
References
- Pérez MT, et al. 2023: L-Asparaginase as the gold standard in the treatment of acute lymphoblastic leukemia: a comprehensive review, Med Oncol. 40(5):150.
- van den Berg H. 2011: Asparaginase revisited, Leuk Lymphoma 52(2):168-78.
- Batool T, et al. 2016: A comprehensive review on L-asparaginase and its applications, Appl Biochem Biotechnol 178(5):900-23.
- Nunes JCF. 2020: Recent strategies and applications for L-asparaginase confinement , Molecules, 25(24):5827.
- Tsegaye K, et al. 2024: Desirable L-asparaginases for treating cancer and current research trends, Front Microbiol 15:1269282.
- Zhou R, et al. 2023: Possible mechanism of metabolic and drug resistance with L-asparaginase therapy in childhood leukaemia, Front Oncol 13:1070069.
- Asselin BL, et al. 1993: Comparative pharmacokinetic studies of three asparaginase preparations, J Clin Oncol 11(9):1780-6.
- Suresh SA, et al. 2022: A systematic review of recent trends in research on therapeutically significant L-asparaginase and acute lymphoblastic leukemia, Mol Biol Rep 49(12):11281-11287.
- Chand S, et al. 2020: A comprehensive review on microbial L-asparaginase: Bioprocessing, characterization, and industrial applications, Biotechnol Appl Biochem 67(4):619-647.
- Salzer WL, et al. 2014: Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia, Ann N Y Acad Sci 1329:81-92.
- Villanueva-Flores F, et al. 2021: Encapsulation of asparaginase as a promising strategy to improve in vivo drug performance, Pharmaceutics 13(11):1965.
- Juluri KR, et al. 2022: Asparaginase in the treatment of acute lymphoblastic leukemia in adults: current evidence and place in therapy, Blood Lymphat Cancer 12:55–79.